Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Net Change in Cash
Yield10 Bioscience Inc
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Net Change in Cash
-$1.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
35%
|
CAGR 10-Years
15%
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
$673m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-17%
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$139.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Net Change in Cash?
Net Change in Cash
-1.3m
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Net Change in Cash amounts to -1.3m USD.
What is Yield10 Bioscience Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
15%
Over the last year, the Net Change in Cash growth was 57%. The average annual Net Change in Cash growth rates for Yield10 Bioscience Inc have been 15% over the past three years , 35% over the past five years , and 15% over the past ten years .